Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Brain and Cognition Discovery Foundation (BCDF) is a non-profit academic research organization based in Toronto, Canada, dedicated to improving the lives of individuals with brain-related disorders. The foundation specializes in the "Cognitive-Emotional-Metabolic" nexus, investigating the complex interplay between mood disorders, cognitive impairment, and metabolic conditions like obesity and diabetes. Led by Dr. Roger McIntyre, a global leader in psychiatry, BCDF conducts high-impact clinical trials and provides medical education to healthcare professionals worldwide. The organization collaborates extensively with pharmaceutical partners to evaluate the efficacy of various treatments, including GLP-1 agonists and multimodal antidepressants, on cognitive outcomes. BCDF's mission is to translate cutting-edge neuroscience into practical clinical guidelines that enhance patient care and functional recovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Brain and Cognition Discovery Foundation.